These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1698216)
1. Protection against lethal Venezuelan equine encephalitis (VEE) virus infection by cell-free supernatant obtained from immune spleen cells. Huprikar J; Dal Canto MC; Rabinowitz SG J Neurol Sci; 1990 Jul; 97(2-3):143-53. PubMed ID: 1698216 [TBL] [Abstract][Full Text] [Related]
2. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines. I. Description and characterization of adoptive transfer by immune spleen cells. Rabinowitz SG J Infect Dis; 1976 Jul; 134(1):30-8. PubMed ID: 939921 [TBL] [Abstract][Full Text] [Related]
3. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine. Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396 [TBL] [Abstract][Full Text] [Related]
4. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice. Hart MK; Pratt W; Panelo F; Tammariello R; Dertzbaugh M Vaccine; 1997 Mar; 15(4):363-9. PubMed ID: 9141206 [TBL] [Abstract][Full Text] [Related]
5. Host immune responses after administration of inactivated Venezuelan equine encephalomyelitis virus vaccines. II. Kinetics of neutralizing antibody responses in donors and adoptively immunized recipients. Rabinowitz SG J Infect Dis; 1976 Jul; 134(1):39-47. PubMed ID: 181497 [TBL] [Abstract][Full Text] [Related]
6. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Grieder FB; Vogel SN Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925 [TBL] [Abstract][Full Text] [Related]
7. Role for mucosal immune responses and cell-mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus. Elvin SJ; Bennett AM; Phillpotts RJ J Med Virol; 2002 Jul; 67(3):384-93. PubMed ID: 12116032 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054 [TBL] [Abstract][Full Text] [Related]
9. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus. Bennett AM; Lescott T; Phillpotts RJ Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402 [TBL] [Abstract][Full Text] [Related]
10. Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge. Konopka JL; Thompson JM; Whitmore AC; Webb DL; Johnston RE J Virol; 2009 Dec; 83(23):12432-42. PubMed ID: 19793821 [TBL] [Abstract][Full Text] [Related]
11. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. Burke DS; Ramsburg HH; Edelman R J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673 [TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Charles PC; Trgovcich J; Davis NL; Johnston RE Virology; 2001 Jun; 284(2):190-202. PubMed ID: 11384219 [TBL] [Abstract][Full Text] [Related]
13. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus]. Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922 [TBL] [Abstract][Full Text] [Related]
14. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087 [TBL] [Abstract][Full Text] [Related]
15. Extension of the mean time to death of mice with a lethal infection of Venezuelan equine encephalomyelitis virus by antithymocyte serum treatment. Woodman DR; McManus AT; Eddy GA Infect Immun; 1975 Nov; 12(5):1006-11. PubMed ID: 1104481 [TBL] [Abstract][Full Text] [Related]
16. Cross-protective immunity between equine encephalomyelitis viruses in equids. Walton TE; Jochim MM; Barber TL; Thompson LH Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of various analogues of tilorone hydrochloride against Venezuelan equine encephalitis virus in mice. Kuehne RW; Pannier WL; Stephen EL Antimicrob Agents Chemother; 1977 Jan; 11(1):92-7. PubMed ID: 836018 [TBL] [Abstract][Full Text] [Related]
18. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. Schoneboom BA; Lee JS; Grieder FB J Interferon Cytokine Res; 2000 Feb; 20(2):205-15. PubMed ID: 10714557 [TBL] [Abstract][Full Text] [Related]
19. Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells. Rabinowitz SG; Adler WH J Immunol; 1973 May; 110(5):1345-53. PubMed ID: 4348975 [No Abstract] [Full Text] [Related]
20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]